Related references
Note: Only part of the references are listed.Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers
Yih-Leong Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
I. Goldstein et al.
CANCER GENE THERAPY (2011)
Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
Carolyn Y. Zhao et al.
CELL CYCLE (2010)
Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer A Laboratory Companion Study to CALGB 9633
Stephen L. Graziano et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Ana I. Robles et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
C. -H. Gow et al.
ANNALS OF ONCOLOGY (2009)
Mutational spectra of human cancer
Gerd P. Pfeifer et al.
HUMAN GENETICS (2009)
Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer
Ana Belen Custodio et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
30 years and a long way into p53 research
Pierre Hainaut et al.
LANCET ONCOLOGY (2009)
Radiotherapy of lung cancer: Technology meets biology meets multidisciplinarity
Michael Baumann et al.
RADIOTHERAPY AND ONCOLOGY (2009)
When mutants gain new powers: news from the mutant p53 field
Ran Brosh et al.
NATURE REVIEWS CANCER (2009)
Progress and challenges in selected areas of tobacco carcinogenesis
Stephen S. Hecht
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Oncogenomic approaches in exploring gain of function of mutant p53
Sara Donzelli et al.
CURRENT GENOMICS (2008)
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells
R. Magrini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer
Daniela Kandioler et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Molecular genetics of lung cancer in people who have never smoked
Janakiraman Subramanian et al.
LANCET ONCOLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small-cell lung cancer
Ming-Sound Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Shaping genetic alterations in human cancer: The p53 mutation paradigm
Thierry Soussi et al.
CANCER CELL (2007)
Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways
Hoseok Song et al.
CELL CYCLE (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
Reactivation of mutant p53: molecular mechanisms and therapeutic potential
G. Selivanova et al.
ONCOGENE (2007)
Strategies for therapeutic targeting of the p53 pathway in cancer
K. G. Wiman
CELL DEATH AND DIFFERENTIATION (2006)
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience
T Soussi et al.
NATURE REVIEWS CANCER (2006)
The role of p53 in treatment responses of lung cancer
K Viktorsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
VJN Bykov et al.
ONCOGENE (2005)
Mortality from lung cancer and tobacco smoking in Ohio (US): Will increasing smoking prevalence reverse current decreases in mortality?
JE Tyczynski et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
P53 abnormalities and outcomes in colorectal cancer: a systematic review
AJ Munro et al.
BRITISH JOURNAL OF CANCER (2005)
Lung cancer mortality patterns in selected central, eastern and southern European countries
JE Tyczynski et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
p53: 25 years after its discovery
LJ Hofseth et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Novel treatments in non-small cell lung cancer
WT Leslie et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
The TP53 gene, tobacco exposure, and lung cancer
S Toyooka et al.
HUMAN MUTATION (2003)
Lung cancer in Europe in 2000: epidemiology, prevention, and early detection
JE Tyczynski et al.
LANCET ONCOLOGY (2003)
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
GP Pfeifer et al.
ONCOGENE (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
U Vogt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke:: lessons from the IARC TP53 mutation database
P Hainaut et al.
MUTAGENESIS (2001)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
E Steels et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection
D Weill et al.
CHEST (2000)
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons
LE Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
J Nemunaitis et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
